Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Comparative genomics reveals new molecular targets for accelerated strain improvement of rifamycin B-producing strains


ABSTRACT: In the present study, we have used a genomic approach to understand how the classical mutate-and-screen method actually generated an improved rifamycin B producer. Compared with the reference strains Amycolatopsis mediterranei S699 (rifamycin B producer) and U32 (rifamycin SV producer), a total of 250 variations affecting a total of 227 coding sequences (CDS) were found in rifamycin B overproducing strain HP-130. One hundred nine CDS variations were specific to HP-130 as they were absent in both S699 and U32. A lot of variations affected genes coding for fatty acid (an lipid) metabolism, which is tightly interconnected with rifamycin biosynthesis by common metabolic precursors (malonyl-CoA, methylmalonyl-CoA). Interestingly, a nonsense mutation was mapped within mutB coding for methylmalonyl-CoA mutase suggesting the importance of metabolic re-direction of carbon flow toward rifamycin biosynthesis in the over-producing phenotype of HP-130. Other key mutations were: i.) a missense mutation affecting ppk, which encodes a polyphosphate kinase and was previously shown to play a negative role in the control of antibiotic biosynthesis in Streptomyces lividans; ii.) a missense mutation in argS2 affecting one of the two arginyl tRNA synthetases of A. mediterranei; iii.) a missense mutation in rifN coding for a protein belonging to the ROK family of transcriptional regulators with kanosamine kinase activity. Microarray analysis of the transcriptome of HP-130 as compared to that of S699 was useful to understand the effects of several mutations on global gene expression profile. Genomic and transcriptomic data were used to improve rifamycin B production in S699 by genetic engineering thus proving the causative effect of the above-mentioned mutations on the overproducing phenotype. In this study by using comparative genomic analysis we have identified all genetic changes that have occurred during development of a rifamycin B overproducer (HP-130), which was obtained by the traditional mutate-and-screen method. To gain insight about the mechanisms underlying improved rifamycin B production in HP-130, DNA microarray of A. mediterranei were manufactured and used for comparative analysis of the gene expression profile in HP-130 and S699. In DNA microarray experiments the two strains were cultivated under standard batch-culture conditions in modified RFB 2244 fermentation medium, and samples were collected at different time points (24-72 h) for RNA extraction. Gene expression data were analyzed to identify transcripts modulated during the growth curve. Amycolatopsis mediterranei S699 (WT) and the improved rifamycin B producer (HP-130) were profiled at 5 time points. For each time point two biological replicates are provided.

ORGANISM(S): Amycolatopsis mediterranei S699

SUBMITTER: Silvio Bicciato 

PROVIDER: E-GEOD-51015 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering.

Peano Clelia C   Damiano Fabrizio F   Forcato Mattia M   Pietrelli Alessandro A   Palumbo Carla C   Corti Giorgio G   Siculella Luisa L   Fuligni Fabio F   Tagliazucchi Guidantonio Malagoli GM   De Benedetto Giuseppe Egidio GE   Bicciato Silvio S   De Bellis Gianluca G   Alifano Pietro P  

Metabolic engineering 20140819


Rifamycins are mainstay agents in treatment of many widespread diseases, but how an improved rifamycin producer can be created is still incompletely understood. Here, we describe a comparative genomic approach to investigate the mutational patterns introduced by the classical mutate-and-screen method in the genome of an improved rifamycin producer. Comparing the genome of the rifamycin B overproducer Amycolatopsis mediterranei HP-130 with those of the reference strains A. mediterranei S699 and U  ...[more]

Similar Datasets

2014-08-26 | GSE51015 | GEO
| PRJNA255942 | ENA
2010-11-10 | E-GEOD-24033 | biostudies-arrayexpress
2016-09-26 | PXD004974 | Pride
2009-04-12 | E-GEOD-12017 | biostudies-arrayexpress
2007-10-08 | GSE6041 | GEO
2013-12-18 | GSE41134 | GEO
2013-12-18 | E-GEOD-41134 | biostudies-arrayexpress
2015-12-31 | E-GEOD-60444 | biostudies-arrayexpress
2015-12-31 | E-GEOD-60396 | biostudies-arrayexpress